Corvus Pharmaceuticals to Provide Business Update and Report Second Quarter 2019 Financial Results on August 1, 2019

NEXT STORY
Helix Biopharma Corp. to Present at RHK Capital Conference in New York
PREV STORY
Salarius Pharmaceuticals Successfully Monetizes Legacy Consumer Product
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

FDA Approves the Roll-Over Combination Study with Checkpoint Inhibitor Immunotherapies to Allow Continued Access to BriaVax™ in Patients with Advanced Breast Cancer

BERKELEY, Calif. and VANCOUVER, British Columbia, Oct. 30, 2017 (GLOBE NEWSWIRE) -- BriaCell Therapeutics ...

author_avatar
NASDAQ Market News

Foresight VCT plc – Half-year report

FORESIGHT VCT PLC Financial Highlights  Total net assets £134.2 million. An interim dividend of ...

author_avatar
NASDAQ Market News

Progenics Announces JAMA Oncology Publication Highlighting Company’s Imaging Analysis Platform

Data Support Prognostic Utility of aBSI as an Imaging Biomarker for Survival in Patients ...

author_avatar
NASDAQ Market News